NEW YORK, March 26 (GenomeWeb News) - Benitec is suing Nucleonics, Ambion, and Genscript in the US for infringing its patent on RNAi technology, the Australian company said yesterday.
Benitec, of Queensland, has filed suits in the US District Court for the District of Delaware, alleging that the three companies are infringing its US Patent No. 6,573,099, entitled "Genetic Constructs for Delaying or Repressing the Expression of a Target Gene." The patent covers DNA-directed RNA interference.
According to Benitec's chairman and CEO, John McKinley, "Benitec will consider additional infringement actions as we deem appropriate in other jurisdictions."